Genomatix appoints distributor for the growing Chinese market

Genomatix Software GmbH of Munich, Germany announced today that it will sell its products to the Chinese market through Beijing ZGZ Science and Technology Development Co., Ltd. ("ZGZ"). Founded in 1998 by the China Biomedicine & Biochemical Academy (China BIB), which provided services exclusively to the Chinese government, ZGZ has become an independent entity last year.

ZGZ is focusing on the research and development in biomedicine, new drug resources, biology information and biometrics research. Based on its rich experience and technological background, ZGZ is active in the international biochip-related field, and will contribute to the China biochip and bioscience community by connecting the western world with China, especially by providing advanced products and services to the Chinese bioscience research.

Genomatix is a pioneer and leader in the analysis and understanding of eukaryotic gene regulation. Core competences at Genomatix are annotation driven microarray analysis, regulatory network and pathway mining, and promoter analysis on sequence level. The entire Genomatix product spectrum, from the integrated microarray analysis pipeline to the MatBase transcription factor knowledge base, will be distributed by ZGZ.

"With more than 1.800 researchers in China being subscribed to our free services today, this represents a very important growth market for us", says Klaus May, Chief Business Officer of Genomatix.

"ZGZ has a professional management team, an outstanding scientific research group plus excellent marketing and sales with strong channels into the Chinese market. All this in combination with their strong ties to China BIB and governmental research institutions will definitely further strengthen Genomatix´ market position in Asia.", he continues. ZGZ is the first distributor in China but the third Asian distributor representing Genomatix.

Genomatix and ZGZ will be present at the "International Forum on Bio-chip Technologies 2006" in Beijing, October 9-12, 2006.

###

About Genomatix:
Genomatix is a pioneer and leader in the analysis and understanding of eukaryotic gene regulation. Technological leadership is complemented by a microarray analysis pipeline. This unique Genomatix-strategy and product integration allows efficient handling of low level analysis from raw expression data (e.g. CEL files), pathway/network analysis, biological classification and identification of the molecular basis for co-regulation on gene promoter level. All Genomatix tools for each step of the analysis have been awarded wit the Affymetrix GeneChip-compatibleTM status. The integrated Genomatix approach allows unparalleled analysis of the full potential of microarray data and generates new knowledge concerning the biological mechanisms involved by superimposing pathway and sequence information. In addition, the analysis time has been drastically reduced, resulting in a significantly enhanced ROI for microarray experiments. Genomatix has published more than 170 peer reviewed scientific papers that have been cited in more than 4,000 papers. Over 32,000 researchers worldwide currently apply Genomatix tools and databases.


Last reviewed: By John M. Grohol, Psy.D. on 21 Feb 2009
    Published on PsychCentral.com. All rights reserved.

 

 

Let me listen to me and not to them.
-- Gertrude Stein